comparemela.com

Latest Breaking News On - Alexr thurman - Page 6 : comparemela.com

84,605 Shares in Glaukos Co (NYSE:GKOS) Acquired by Lisanti Capital Growth LLC

84,605 Shares in Glaukos Co (NYSE:GKOS) Acquired by Lisanti Capital Growth LLC
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Glaukos Co to Post Q1 2024 Earnings of ($0 58) Per Share, Zacks Research Forecasts (NYSE:GKOS)

Glaukos Co. (NYSE:GKOS – Free Report) – Research analysts at Zacks Research upped their Q1 2024 EPS estimates for shares of Glaukos in a report issued on Wednesday, January 3rd. Zacks Research analyst I. Bandyopadhyay now forecasts that the medical instruments supplier will post earnings of ($0.58) per share for the quarter, up from their […]

Glaukos (NYSE:GKOS) PT Raised to $105 00

Glaukos (NYSE:GKOS – Free Report) had its price objective increased by Piper Sandler from $90.00 to $105.00 in a research note issued to investors on Friday morning, Benzinga reports. The firm currently has an overweight rating on the medical instruments supplier’s stock. Other equities research analysts also recently issued research reports about the stock. Stifel […]

Wealthcare Advisory Partners LLC Purchases New Position in Glaukos Co (NYSE:GKOS)

Wealthcare Advisory Partners LLC purchased a new stake in shares of Glaukos Co. (NYSE:GKOS – Free Report) in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 2,706 shares of the medical instruments supplier’s stock, valued at approximately $204,000. Several other institutional investors also recently bought […]

Glaukos Co (NYSE:GKOS) Given Average Recommendation of Moderate Buy by Brokerages

Glaukos Co. (NYSE:GKOS – Get Free Report) has been given a consensus rating of “Moderate Buy” by the eleven ratings firms that are presently covering the stock, MarketBeat.com reports. Two research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. The average 1-year price objective […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.